Joseph J. Basile serves as Executive at iSpecimen Inc., where they oversee executive responsibilities. Since joining the company, Joseph J. Basile has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 1, 2023 involved receiving (via award) 63 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 1, 2023 | ISPC | $0 | Award | 63 | $N/A | Discretionary |
Joseph J. Basile currently holds 63 shares of iSpecimen Inc. (ISPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph J. Basile has been a net neutral trader of ISPC stock. They have purchased $0 and sold $0 worth of shares.
Joseph J. Basile's most recent insider trade was on Jan 1, 2023, when they sold 63 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted